Delivering chemotherapy directly into the abdomen improves survival in women with advanced ovarian cancer, a new study shows.
Doctors randomly assigned 415 women with ovarian cancer that was spreading to nearby tissues to receive either standard chemotherapy intravenously or that therapy plus up to six courses, at 3-week intervals, of chemotherapy injected into the abdomen via a catheter.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.